![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 47/68 | (2017.01) |
A61K 38/17 | (2006.01) | ||
C07K 16/26 | (2006.01) | ||
C07K 16/00 | (2006.01) | ||
A61K 31/395 | (2006.01) | ||
A61K 39/00 | (2006.01) | ||
A61K 31/704 | (2006.01) | ||
A61K 31/7068 | (2006.01) | ||
A61K 39/395 | (2006.01) | ||
A61K 45/06 | (2006.01) | ||
C07K 16/22 | (2006.01) |
(11) | Number of the document | 2951205 |
(13) | Kind of document | T |
(96) | European patent application number | 14746114.9 |
Date of filing the European patent application | 2014-02-03 | |
(97) | Date of publication of the European application | 2015-12-09 |
(45) | Date of publication and mention of the grant of the patent | 2021-08-11 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2014/014490 |
Date | 2014-02-03 |
(87) | Number | WO 2014/121221 |
Date | 2014-08-07 |
(30) | Number | Date | Country code |
201361759961 P | 2013-02-01 | US | |
201361815220 P | 2013-04-23 | US |
(72) |
HAN, Huiquan , US
HAQQ, Christopher, Michael , US
CIECHANOVER, Isaac , US
ZHOU, Xiaolan , US
LU, John, Zhao-nian , US
|
(73) |
Santa Maria Biotherapeutics, Inc. ,
701 Gateway Blvd., Suite 200, South San Francisco, CA 94080,
US
Amgen Inc. , One Amgen Center Drive, Thousand Oaks, California 91320, US |
(54) | ANTI-ACTIVIN-A COMPOUNDS FOR THE TREATMENT OF OVARIAN CANCER |
ANTI-ACTIVIN-A COMPOUNDS FOR THE TREATMENT OF OVARIAN CANCER |